Beranda › Penyakit Hati Steatotik › Texas › Waco
Uji klinis Penyakit Hati Steatotik di Waco, TX
6 studi untuk Penyakit Hati Steatotik mencari peserta di lokasi sekitar Waco (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Menerima pesertaFase 3
- Akero Clinical Study Site, Waco
- Akero Clinical Study Site, Waco
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Menerima pesertaFase 3
- GSK Investigational Site, Waco
- GSK Investigational Site, Waco
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Menerima pesertaFase 3
- 89bio Clinical Study Site, Waco
- 89bio Clinical Study Site, Waco
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Menerima pesertaFase 3
- 89bio Clinical Study Site, Waco
- 89bio Clinical Study Site, Waco
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Menerima pesertaFase 3
- GSK Investigational Site, Waco
- GSK Investigational Site, Waco
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Menerima pesertaFase 2
- GSK Investigational Site, Waco
Uji klinis Penyakit Hati Steatotik di kota lain
- San Antonio, TX17 studi
- New York City, NY16 studi
- Miami, FL16 studi
- San Diego, CA14 studi
- Houston, TX13 studi
- Austin, TX13 studi
- Richmond, VA12 studi
- Chandler, AZ10 studi
- Tucson, AZ10 studi
- Orlando, FL9 studi
- Hialeah, FL9 studi
- St. Louis, MO9 studi
Studi lain di Waco
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.